Sarah Peterson
Obstetrics & Gynecology · Stanford, CANPI 1205256872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 29.6% of the total. Reporting peaked in 2023 at $656 and has fallen 85.4% since, to $96 in 2025.
Across 83 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$510
- Astellas Pharma US Inc$319
- Mayne Pharma Commercial LLC$204
- Bayer$149
- Hologic Sales And Service, LLC$88
- Exeltis, USA Inc.$64
- plus $390 from 15 others
What the payments were for
- Food & beverage$1,62594%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $510 |
| Astellas Pharma US Inc | 9 | $319 |
| Mayne Pharma Commercial LLC | 9 | $204 |
| Bayer | 7 | $149 |
| Hologic Sales And Service, LLC | 4 | $88 |
| Exeltis, USA Inc. | 3 | $64 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Organon | 2 | $46 |
| Sage Therapeutics, LLC | 3 | $44 |
| Laborie Medical Technologies Corp. | 1 | $38 |
| Pfizer | 2 | $31 |
| Coopersurgical, Inc. | 2 | $29 |
| Baxter Healthcare | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| Innovation Technologies Inc | 1 | $22 |
| Exact Sciences | 1 | $20 |
| Teleflex LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Medtronic | 1 | $13 |
| Merck | 1 | $12 |
How this compares
$1,725 in reported general payments places this provider in the 70th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,337 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Stanford
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.